Xtant Medical Holdings Inc. (AMEX:XTNT) went down by -0.41% from its latest closing price compared to the recent 1-year high of $3.50. The company’s stock price has collected 2.59% of gains in the last five trading sessions. Press Release reported 7 hours ago that Xtant Medical Announces Closing of Debt Restructuring
Is It Worth Investing in Xtant Medical Holdings Inc. (AMEX :XTNT) Right Now?
Plus, the 36-month beta value for XTNT is at 1.56. Opinions of the stock are interesting as 0 analysts out of 1 who provided ratings for Xtant Medical Holdings Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $1.00, which is $0.18 above the current price. XTNT currently public float of 13.01M and currently shorts hold a 0.17% ratio of that float. Today, the average trading volume of XTNT was 989.20K shares.
XTNT’s Market Performance
XTNT stocks went up by 2.59% for the week, with a monthly drop of -12.55% and a quarterly performance of -15.43%, while its annual performance rate touched -70.91%. The volatility ratio for the week stands at 7.39% while the volatility levels for the past 30 days are set at 8.17% for Xtant Medical Holdings Inc.. The simple moving average for the period of the last 20 days is -1.08% for XTNT stocks with a simple moving average of -23.39% for the last 200 days.
Analysts’ Opinion of XTNT
Many brokerage firms have already submitted their reports for XTNT stocks, with Maxim Group repeating the rating for XTNT by listing it as a “Buy.” The predicted price for XTNT in the upcoming period, according to Maxim Group is $6 based on the research report published on November 15th of the previous year 2018.
Maxim Group, on the other hand, stated in their research note that they expect to see XTNT reach a price target of $10, previously predicting the price at $18. The rating they have provided for XTNT stocks is “Buy” according to the report published on February 14th, 2018.
XTNT Trading at -16.60% from the 50-Day Moving Average
After a stumble in the market that brought XTNT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -76.56% of loss for the given period.
Volatility was left at 8.17%, however, over the last 30 days, the volatility rate increased by 7.39%, as shares sank -5.40% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -28.67% lower at present.
During the last 5 trading sessions, XTNT rose by +2.59%, which changed the moving average for the period of 200-days by -51.75% in comparison to the 20-day moving average, which settled at $0.8269. In addition, Xtant Medical Holdings Inc. saw -48.73% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for XTNT
Current profitability levels for the company are sitting at:
- -3.48 for the present operating margin
- +65.64 for the gross margin
The net margin for Xtant Medical Holdings Inc. stands at -12.71. The total capital return value is set at -11.65, while invested capital returns managed to touch -43.64. Equity return is now at value 18.70, with -19.80 for asset returns.
Currently, EBITDA for the company is 85,000 with total debt to EBITDA at 77.15. When we switch over and look at the enterprise to sales, we see a ratio of 1.41, with the company’s debt to enterprise value settled at 0.83. The receivables turnover for the company is 6.43 and the total asset turnover is 1.44. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.43.